New Molecular Targets Found in Melanoma

(Ivanhoe Newswire) –Recent research has found two novel BRAF fusions in melanomas that were previously considered to be negative for molecular targets, and melanomas with these fusions were found to be potentially sensitive to anticancer drugs known as MEK inhibitors.

Source: Medical Headlines From Ivanhoe.com - December 19, 2013 Category: Consumer Health News Source Type: news